Rowe D E, Carroll R J, Day C L
University of Texas Health Science Center, San Antonio.
J Am Acad Dermatol. 1992 Jun;26(6):976-90. doi: 10.1016/0190-9622(92)70144-5.
We reviewed all studies since 1940 on the prognosis of squamous cell carcinoma (SCC) of the skin and lip. The following variables are correlated with local recurrence and metastatic rates: (1) treatment modality, (2) prior treatment, (3) location, (4) size, (5) depth, (6) histologic differentiation, (7) histologic evidence of perineural involvement, (8) precipitating factors other than ultraviolet light, and (9) host immunosuppression. Local recurrences occur less frequently when SCC is treated by Mohs micrographic surgery. This local recurrence rate differential in favor of Mohs micrographic surgery holds true for primary SCC of the skin and lip (3.1% vs 10.9%), for ear SCC (5.3% vs 18.7%), for locally recurrent (previously treated) SCC (10% vs 23.3%), for SCC with perineural involvement (0% vs 47%), for SCC of size greater than 2 cm (25.2% vs 41.7%), and for SCC that is poorly differentiated (32.6% vs 53.6%).
我们回顾了自1940年以来关于皮肤和唇部鳞状细胞癌(SCC)预后的所有研究。以下变量与局部复发率和转移率相关:(1)治疗方式,(2)既往治疗,(3)部位,(4)大小,(5)深度,(6)组织学分化程度,(7)神经周围侵犯的组织学证据,(8)紫外线以外的诱发因素,以及(9)宿主免疫抑制。当采用莫氏显微外科手术治疗SCC时,局部复发的情况较少见。这种有利于莫氏显微外科手术的局部复发率差异在皮肤和唇部原发性SCC(3.1%对10.9%)、耳部SCC(5.3%对18.7%)、局部复发性(既往治疗过的)SCC(10%对23.3%)、伴有神经周围侵犯的SCC(0%对47%)、大小大于2 cm的SCC(25.2%对41.7%)以及低分化SCC(32.6%对53.6%)中均成立。